Skip to content
ClinCalc Pro
Menu
Pre-mixed insulin analogue

Biphasic insulin lispro

Brand names: Humalog Mix25, Humalog Mix50

A premixed (biphasic) insulin combining rapid-acting insulin lispro with an intermediate-acting protaminated component, given by subcutaneous injection for diabetes mellitus. This page covers the premixed formulation and its mealtime-related risks.

Dosing — set by the prescriber

The product information gives no fixed dose: it is individual and set by the prescriber, or by your local protocol. See the product SmPC.

Clinical monograph

How it works

The rapid-acting lispro fraction controls post-meal glucose while the protaminated fraction provides a longer background effect; both lower blood glucose by enhancing cellular glucose uptake and reducing hepatic glucose production.

Prescribing in practice

  • Hypoglycaemia is the principal hazard — the rapid component acts promptly, so the dose must be matched to meals and given in close relation to eating.
  • Resuspend the cloudy suspension gently before each dose and never give it intravenously.
  • Insulin requirements vary with illness, exercise, weight and renal function, and changes between insulin brands should be supervised.

Monitoring

Monitor capillary and longer-term blood glucose (HbA1c), injection sites and for hypoglycaemia, adjusting doses to meals and activity.

Counselling the patient

  • Mix the pen until evenly cloudy and inject around mealtimes as directed.
  • Know how to recognise and treat a hypo, and rotate injection sites.
  • Never share pens or needles and review monitoring when unwell.

Evidence & guidelines

Premixed insulin lispro is supported by randomised trials showing effective control of post-prandial and overall glycaemia in diabetes.

Reference: NICE NG28; NICE NG17; JBDS; Confirm identity and dosing against the manufacturer SPC (eMC) and NICE. Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.